Showing results 31 to 50 of 174
< previous
next >
Issue Date | Title | Author(s) |
2014 | Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometers | Kozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan |
2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
2014 | Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2014 | Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cells | Yandım, Melis Kartal; Baran, Yusuf |
2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
2010 | Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Baran, Yusuf |
2011 | Deciphering 5-fluorouracil mediated molecular mechanisms required for cell death | Can, Geylani |
2013 | Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cells | Baran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali |
Jul-2021 | Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cells | Abdulhadi, Nusaibah Abdulsalam Abdulhad |
2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
Jul-2019 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe |
Dec-2019 | Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cells | Uzuner, Erez |
Nov-2019 | Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cells | Gürler, Sevim Beyza |
2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
2013 | Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients | Baran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali |
2015 | Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patients | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf |
Jun-2009 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells | Güçlüler, Gözde; Baran, Yusuf |
Feb-2009 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells | Karabulut, B.; Erten, C.; Gül, M. K.; Cengiz, E.; Karaca, B.; Küçükzeybek, Y.; Görümlü, G.; Atmaca, H.; Uzunoğlu, S.; Şanlı, U. A.; Baran, Yusuf ; Uslu, R. |
Jul-2011 | Effect of cobalt-60 (? radiation) on multidrug-resistant multiple myeloma cell lines | Mutlu, Pelin; Baran, Yusuf ; Ural, Ali Ugur; Avcu, Ferit; Dirican, Bahar; Beyzadeoglu, Murat; Gündüz, Ufuk |
Sep-2017 | Effect of molecular architecture on cell interactions and stealth properties of PEG | Özer, İmran; Tomak, Aysel ; Zareie, Hadi M.; Baran, Yusuf ; Bulmuş, Volga |